11 December 2015 - The U.S. FDA today approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving these cancer treatments.

For more details, go to: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm476919.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery